Bio-Techne Corp at JPMorgan Healthcare Conference Transcript
Hi, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at JPMorgan. Today, I am joined by Jim Hippel from the Bio-Techne team. This will be a standard 40-minute presentation, 20 minutes of slides, followed by 20 minutes of Q&A. For those of you listening online via webcast, feel free to submit your questions via the Q&A function. And for those of you in the room, we will have mic runners. So if you have a question, feel free to raise your hand.
With that, Jim?
Thank you. Good morning, everyone. Thanks for joining us this morning, and thank you to JPMorgan for having us for the conference. And unfortunately, Chuck fell ill, our CEO, Chuck Kummeth fell ill yesterday and was still recovering this morning. So I got the call to take his place. And in doing so, he reminded me that 9 years ago was the first time ever in the history of our 40-year company that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
